DCAKD抗体—艾普蒂

+ +

•  

   

     Gel: 12%SDS-PAGE, Lysate: 40 μg, Lane: Mouse placenta tissue lysate, Primary antibody: P02596(DCAKD Antibody) at dilution 1/800, Secondary antibody: Goat anti rabbit IgG at 1/5000 dilution, Exposure time: 5 minutes    

  
  

The DCAKD antibody is a novel research tool developed to target the DCAKD protein, a recently identified antigen implicated in various cellular processes. While the exact biological role of DCAKD remains under investigation, preliminary studies suggest its involvement in intracellular signaling pathways, particularly those related to cell proliferation and apoptosis. Researchers hypothesize that DCAKD may function as a regulatory protein in kinase-dependent cascades, potentially influencing oncogenic pathways in certain cancers.

This antibody has gained attention in oncology research due to its ability to selectively bind DCAKD epitopes, enabling scientists to visualize protein localization through immunohistochemistry and monitor expression levels in disease models. Early-phase studies indicate elevated DCAKD expression in colorectal and breast cancer tissues compared to normal samples, positioning it as a potential diagnostic biomarker or therapeutic target.

Current applications focus on both basic research—elucidating DCAKD's molecular interactions—and preclinical drug development. The antibody's humanized design enhances compatibility for potential future therapeutic use, though clinical validation remains pending. Challenges include clarifying DCAKD's exact mechanistic role and establishing standardized detection protocols across tissue types. As research progresses, DCAKD antibodies could contribute to personalized medicine approaches, particularly in cancers showing pathway dysregulation.